יתרות מזומנים למניה אחת KORU Medical Systems, Inc. (KRMD)

The medical equipment market requires a balance between environmental sustainability and the sterility of disposable components. The current cash per share reflects price action where the 0.17 level serves as a critical mark. The stability of KORU Medical Systems (KRMD) depends on FDA approvals and insurance reimbursements, while a loyal engineering staff ensures the high quality of home infusion systems.
פילוחים אנליטיים של חברת KORU Medical Systems

For the investor, assessing the liquidity of KORU Medical Systems (KRMD) is critical given the vulnerability of biopharmaceutical supply chains and the regulatory barriers associated with conducting international trials. Cash per share data determines the volume of available capital to cover operating expenses without incurring external debt. An increase in this indicator confirms the business's financial stability, whereas an excess of non-working assets may signal inefficient asset management.